• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR PROSTAR XL SUTURE-MEDIATED CLOSURE; VESSEL CLOSURE SUTURE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR PROSTAR XL SUTURE-MEDIATED CLOSURE; VESSEL CLOSURE SUTURE Back to Search Results
Catalog Number 12322-01
Medical Device Problem Code Failure to Fire (2610)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 04/02/2024
Type of Reportable Event Serious Injury
Event or Problem Description
It was reported that an arteriotomy closure of an unspecified access site was attempted with a prostar device after a thoracic endovascular aortic repair interventional procedure.Reportedly, needle at the 10-o-clock position missed the intended opening on the device with two prostar devices.A cut-down with surgical suturing were performed to achieve hemostasis.There was no clinically significant delay in the procedure or therapy.No additional information was provided.
 
Additional Manufacturer Narrative
B3- the date of procedure will be estimated as (b)(6) 2024.Manufacturer's investigation is still pending at this time.Results and conclusions will be provided in the final report.The additional prostar referenced in b5 is filed under a separate medwatch report number.
 
Additional Manufacturer Narrative
The device was not returned for analysis.Production record and corrective and preventive actions (capa) reviews were performed and revealed no indication of a product quality issue.Additionally, a query of the complaint handling database for the reported lot revealed there is no indication of a lot specific issue.A conclusive cause for the reported issue cannot be determined as the device was not returned for analysis.Factors that may contribute to the reported failure to deploy the needles may include, but are not limited to, clamped suture lumens, change position of device during deployment, device orientation.The subsequent treatment appears to be related to circumstances of the procedure.Based on review, there is no indication of a product quality issue with respect to the design, manufacture, or labeling of the device.Correction: d9 - device available for evaluation updated from ¿yes¿ to ¿no¿.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PROSTAR XL SUTURE-MEDIATED CLOSURE
Common Device Name
VESSEL CLOSURE SUTURE
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
Manufacturer (Section G)
ABBOTT VASCULAR, REG # 3005718570 (P099)
cashel road
clonmel tipperary
EI  
Manufacturer Contact
lindsey bell
26531 ynez rd.
temecula, CA 92591-4628
9519143996
MDR Report Key19174828
Report Number2024168-2024-05050
Device Sequence Number7085902
Product Code MGB
UDI-Device Identifier08717648000621
UDI-Public(01)08717648000621(17)250930(10)3111441
Combination Product (Y/N)N
Initial Reporter StateWA
Initial Reporter CountryUS
PMA/510(K) Number
P960043
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 06/05/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date09/30/2025
Device Catalogue Number12322-01
Device Lot Number3111441
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 04/03/2024
Supplement Date Received by Manufacturer06/03/2024
Initial Report FDA Received Date04/24/2024
Supplement Report FDA Received Date06/05/2024
Was Device Evaluated by Manufacturer? (Y/N) No
Date Device Manufactured11/14/2023
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient SexUnknown
-
-